These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34269294)
1. BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation. Li X; Guo M; Yang L; Cheng Z; Yu X; Han Z; Liu F; Sun Q; Han X; Yu J; Liang P J Cancer Res Ther; 2021 Jul; 17(3):644-651. PubMed ID: 34269294 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168 [TBL] [Abstract][Full Text] [Related]
3. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
4. Predictive effects of a combined indicator in patients with hepatocellular carcinoma after thermal ablation. Yang Q; Yu XL; Wang Y; Cheng ZG; Han ZY; Liu FY; Qian TG; Yu J; Liang P J Cancer Res Ther; 2020 Sep; 16(5):1038-1050. PubMed ID: 33004745 [TBL] [Abstract][Full Text] [Related]
5. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice. Wang J; Dong L; Xu L; Chu ES; Chen Y; Shen J; Li X; Wong CC; Sung JJ; Yu J Cancer Lett; 2014 Dec; 355(2):192-200. PubMed ID: 25218345 [TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance. Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860 [TBL] [Abstract][Full Text] [Related]
7. Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma. Chen XH; Wu WG; Ding J Tumour Biol; 2014 Feb; 35(2):967-71. PubMed ID: 24006221 [TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
9. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma. Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma. Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036 [TBL] [Abstract][Full Text] [Related]
11. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation. Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724 [TBL] [Abstract][Full Text] [Related]
12. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Lee S; Rhim H; Kim YS; Kang TW; Song KD Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910 [TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes. Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma. Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005 [No Abstract] [Full Text] [Related]
15. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma. Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620 [TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study. Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917 [TBL] [Abstract][Full Text] [Related]
17. BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis. Wang W; Huang P; Wu P; Kong R; Xu J; Zhang L; Yang Q; Xie Q; Zhang L; Zhou X; Chen L; Xie H; Zhou L; Zheng S Oncotarget; 2015 Aug; 6(24):20252-65. PubMed ID: 25970780 [TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097 [TBL] [Abstract][Full Text] [Related]
19. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724 [TBL] [Abstract][Full Text] [Related]
20. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy. Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]